论文部分内容阅读
Despite many disadvantages, such as rapid in vivo circulation and renal toxicity, clinical iodine-based contrast agent cant be replaced by new contrast agent-gold nanoparticle (AuNPs) possessing high market cost of gold which is directly proportional to high concentrations needed for computed tomography (CT) imaging [1].